Press ReleaseBipartisan2026-06-01

Congressman Allen Leads Colleagues in Calling on the EBSA to Enforce PBM Reforms

Environment

Context

This press release from Representative Rick W. Allen (R-GA) was published on 2026-06-01 and titled "Congressman Allen Leads Colleagues in Calling on the EBSA to Enforce PBM Reforms".

Full Text

Congressman Allen Leads Colleagues in Calling on the EBSA to Enforce PBM Reforms

Today, Congressman Rick W. Allen (GA-12) was joined by Reps. Mariannette Miller-Meeks (IA-01), Nicole Malliotakis (NY-11), Nanette Barragán (CA-44), Lucy McBath (GA-06), and Bradley Schneider (IL-10) in sending a letter to the Honorable Daniel Aronowitz, Assistant Secretary of the Employee Benefits Security Administration (EBSA) at the U.S. Department of Labor (DOL). The letter urges the EBSA to exercise its enhanced authority to enforce the landmark reforms designed to rein in the abuses of pharmacy benefit managers (PBMs), as required by law via the Consolidated Appropriations Act of 2026 (CAA). In the letter, the Members write: "The CAA represents years of bipartisan work to increase the accountability and transparency of PBMs’ opaque business practices, which have contributed to rising costs and diminished access to medicines for American patients and employers. The enactment of the CAA’s provisions is a significant step toward increased PBM transparency." The Members continue: "However, meaningful implementation will require active oversight and guidance from the Department of Labor (DOL) and the Employee Benefits Security Administration (EBSA). We write to urge EBSA to exercise its enhanced authority to give full effect to these reforms, as Congress intended." The Members conclude: "Robust implementation of the rebate pass-through requirement and the bona fide service fee standard will help ensure the following: PBMs no longer have a financial incentive to favor more expensive medicines over generics or biosimilars. Patients benefit from the rebates and discounts negotiated on their behalf. Employers and plan fiduciaries gain meaningful transparency into the compensation arrangements and services provided by their PBMs. We urge EBSA to use every tool at its disposal to translate this legislative intent into durable, enforceable standards." BACKGROUND: The Consolidated Appropriations Act of 2026 was signed into law by President Donald Trump on February 3, 2026. Congressman Rick Allen has long called for major PBM reforms—helping champion the reforms included in the CAA, and most recently with the introduction of the PBM Kickback Prohibition Act , which was advanced by the Education and Workforce Committee on May 21, 2026. To read the full letter to the Honorable Daniel Aronowitz, click here .

View original source →

Congressman Allen Leads Colleagues in Calling on the EBSA to Enforce PBM Reforms Today, Congressman Rick W. Allen (GA-12) was joined by Reps. Mariannette Miller-Meeks (IA-01), Nicole Malliotakis (NY-11), Nanette Barragán (CA-44), Lucy McBath (GA-06), and Bradley Schneider (IL-10) in sending a letter to the Honorable Daniel Aronowitz, Assistant Secretary of the Employee Benefits Security Administration (EBSA) at the U.S. Department of Labor (DOL). The letter urges the EBSA to exercise its enhanced authority to enforce the landmark reforms designed to rein in the abuses of pharmacy benefit managers (PBMs), as required by law via the Consolidated Appropriations Act of 2026 (CAA). In the letter, the Members write: "The CAA represents years of bipartisan work to increase the accountability and transparency of PBMs’ opaque business practices, which have contributed to rising costs and diminished access to medicines for American patients and employers. The enactment of the CAA’s provisions is a significant step toward increased PBM transparency." The Members continue: "However, meaningful implementation will require active oversight and guidance from the Department of Labor (DOL) and the Employee Benefits Security Administration (EBSA). We write to urge EBSA to exercise its enhanced authority to give full effect to these reforms, as Congress intended." The Members conclude: "Robust implementation of the rebate pass-through requirement and the bona fide service fee standard will help ensure the following: PBMs no longer have a financial incentive to favor more expensive medicines over generics or biosimilars. Patients benefit from the rebates and discounts negotiated on their behalf. Employers and plan fiduciaries gain meaningful transparency into the compensation arrangements and services provided by their PBMs. We urge EBSA to use every tool at its disposal to translate this legislative intent into durable, enforceable standards." BACKGROUND: The Consolidated Appropriations Act of 2026 was signed into law by President Donald Trump on February 3, 2026. Congressman Rick Allen has long called for major PBM reforms—helping champion the reforms included in the CAA, and most recently with the introduction of the PBM Kickback Prohibition Act , which was advanced by the Education and Workforce Committee on May 21, 2026. To read the full letter to the Honorable Daniel Aronowitz, click here .